Want electric vehicle exposure on the ASX? This company just might be the best one
Nick Sundich, June 14, 2023
If you want electric vehicle exposure on the ASX, there’s not many options. But one of them is IPD Group (ASX:IPG), which provides electrical infrastructure, including necessary infrastructure for EVs (including chargers). And it just told shareholders to expect significant earnings growth in FY23.
Do you need solid trading & investment ideas on ASX?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
A big FY23 earnings update
The company generated $20.2m in EBITDA and $16.6m in EBIT during FY22. It told shareholders this morning that FY23 had proven to be a strong year given ‘the tailwinds of the electrification of the economy’.
Based upon unaudited accounts for the 11 months in FY23 to date, it is expecting $27.1-$27.6m in EBITDA (representing 34-36% growth) and $22.9-$23.4m in EBIT (up 38-41%). The EBITDA guidance is 3-4% higher than consensus estimates, which called for $26.4m.
The company with electric vehicle exposure on the ASX has tripled since listing
Given its IPD Group listed in late 2021, you’d expect it to be down. But after listing at $1.20, it has more than tripled.
IPD (ASX:IPG) share price chart, log scale (Source: TradingView)
It isn’t hard to see why when the stock is performing as well as it is and the long-term thematic. You may not be able to invest in any electric vehicle makers on the ASX. But if you want some kind of electric vehicle exposure on the ASX, this just might be the next best thing.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
There’s no credit card needed – the trial will expire automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Paradigm Biopharmaceuticals (ASX:PAR): An osteoarthritis solution that could hit the market within 3 years
If you thought the were plenty of treatments for osteoarthritis already, Paradigm Biopharmaceuticals (ASX:PAR) is a company that has something…
Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017
Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…
CET1 ratio: If you invest in ASX bank stocks, here’s why it is an important metric to know
In this article we look at the Common Equity Tier 1 (CET1) ratio – what it is and why it…